pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Opioid Overdose Deaths Have Plummeted, Experts Call for Deeper Investigation

Oct 23, 2026·read at STAT ↗Positive

Recent data indicate a steep drop in opioid overdose deaths. The decline is notable compared with previous years.

Three health experts argue that influences beyond medical treatment and public health policies are likely the main drivers of this change. They point to social, economic or behavioral factors that may be reducing fatal overdoses.

The experts urge researchers and policymakers to investigate these underlying forces so the downward trend can be understood and maintained.

source

This writeup was produced by pharmadog from original reporting by STAT. The original article may no longer be reachable at its published URL.

Original headline: “Opinion: Overdose deaths have plunged. We need to know why”

read at STAT ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoOne family’s story of a life-extending medicine for pancreatic cancerSTAT
  • 2h agoHow a targeted drug kept one patient alive 15 years — but failed to save her friendsSTAT
  • 2h agoSTAT reporters react to the new Elizabeth Holmes documentarySTAT
  • 2h agoOpinion: New Medicare policies will keep important pain relief from some patientsSTAT
  • 2h agoSTAT+: State officials scrambling to implement Medicaid work requirements meet up to swap notesSTAT